Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar

Kay, J, Dörner, T, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar. Annals of the Rheumatic Diseases, 79 (4). e44. ISSN 0003-4967

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This is an author produced version of an article published in Annals of the Rheumatic Diseases. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 2 January 2019
  • Published (online): 18 January 2019
  • Published: April 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Apr 2019 12:57
Last Modified: 27 Mar 2020 16:13
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2018-214994

Export

Statistics